Ascorbic acid: clinical trials recruiting now
FDA drug label
- FDA-approved
- Yes. Ascorbic acid appears in the FDA drug-label database. Marketed as Ascorbic Acid.
- Drug class
- Vitamin C (FDA established pharmacologic class)
FDA-approved use
Ascorbic acid injection is indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients, age 5 months and older, for whom oral administration is not possible, insufficient or contraindicated. Limitations of Use Ascorbic acid injection is not indicated for the treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy. Ascorbic acid injection is vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administration is not possible, insufficient or contraindicated. Limitations of Use Ascorbic acid injection is not indicated for treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy.
Phase breakdown
Conditions being studied
| Condition | Trials |
|---|---|
| Hypertension | 2 |
| Blood Pressure | 1 |
| Lung Cancer | 1 |
| Obesity | 1 |
Recruiting trials involving Ascorbic acid
- Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
- Reversing Glucose and Lipid-mediated Vascular Dysfunction
- Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
Common questions
Is Ascorbic acid FDA-approved?
Yes, marketed as Ascorbic Acid.
How many recruiting trials involve Ascorbic acid?
3 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.